Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 38,429 | 64,998 | 44,032 | 42,888 | 24,401 |
| Cost of Goods | 3,401 | 2,616 | 2,207 | 3,076 | 970 |
| Gross Profit | 35,028 | 62,382 | 41,825 | 39,812 | 23,431 |
| Operating Expenses | 105,856 | 120,997 | 9,702 | 125,025 | 105,475 |
| Operating Income | -70,427 | -57,999 | 32,330 | -85,137 | -81,074 |
| Interest Expense | 501 | 538 | 580 | 651 | 633 |
| Other Income | -453 | 262 | 1,482 | 644 | 3,165 |
| Pre-tax Income | -71,381 | -58,275 | 33,232 | -85,144 | -78,542 |
| Income Tax | 134 | 170 | 215 | 169 | -194 |
| Net Income Continuous | -71,755 | -58,634 | 33,004 | -85,313 | -78,348 |
| Net Income | $-71,755 | $-58,634 | $33,004 | $-85,313 | $-78,348 |
| EPS Basic Total Ops | -19.50 | -15.75 | 9.00 | -23.75 | -22.25 |
| EPS Basic Continuous Ops | -19.57 | -15.73 | 9.11 | -23.84 | -22.20 |
| EPS Diluted Total Ops | -19.50 | -15.50 | 8.75 | -23.75 | -22.25 |
| EPS Diluted Continuous Ops | -19.57 | -15.43 | 8.81 | -23.84 | -22.20 |
| EBITDA(a) | $-64,957 | $-52,509 | $38,028 | $-79,494 | $-75,755 |